Tacrolimus injection
Products billed under this code include Prograf, Tacrolimus.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Prograf, Tacrolimus.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Prograf | Astellas Pharma US, Inc. | 00469-3016-01 | 10 | $2,420.73 |
| Tacrolimus | Nexus Pharmaceuticals, LLC | 14789-0135-05 | 10 | $2,420.73 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $242.073 | −$26.103 | 5 MG | Tacrolimus injection | v1, posted September 17, 2026 |
| 3Q26 | $268.176 | +$8.22 | 5 MG | Tacrolimus injection | v1, posted September 15, 2026 |
| 2Q26 | $259.956 | −$2.493 | 5 MG | Tacrolimus injection | v1, posted September 15, 2026 |
| 1Q26 | $262.449 | −$0.699 | 5 MG | Tacrolimus injection | v1, posted September 15, 2026 |
| 4Q25 | $263.148 | +$0.918 | 5 MG | Tacrolimus injection | v1, posted September 8, 2026 |
| 3Q25 | $262.23 | +$7.172 | 5 MG | Tacrolimus injection | v1, posted March 10, 2026 |
| 2Q25 | $255.058 | +$0.392 | 5 MG | Tacrolimus injection | v1, posted March 10, 2026 |
| 1Q25 | $254.666 | −$0.109 | 5 MG | Tacrolimus injection | v1, posted December 19, 2025 |
| 4Q24 | $254.775 | +$1.168 | 5 MG | Tacrolimus injection | v1, posted June 11, 2025 |
| 3Q24 | $253.607 | +$4.837 | 5 MG | Tacrolimus injection | v1, posted June 11, 2025 |
| 2Q24 | $248.77 | +$0.035 | 5 MG | Tacrolimus injection | v1, posted March 11, 2025 |
| 1Q24 | $248.735 | −$0.01 | 5 MG | Tacrolimus injection | v1, posted December 19, 2024 |
| 4Q23 | $248.745 | +$2.66 | 5 MG | Tacrolimus injection | v1, posted October 10, 2024 |
| 3Q23 | $246.085 | +$12.167 | 5 MG | Tacrolimus injection | v1, posted June 5, 2024 |
| 2Q23 | $233.918 | +$0.166 | 5 MG | Tacrolimus injection | v1, posted February 23, 2024 |
| 1Q23 | $233.752 | +$0.148 | 5 MG | Tacrolimus injection | v1, posted December 6, 2023 |
| 4Q22 | $233.604 | +$2.381 | 5 MG | Tacrolimus injection | v1, posted June 22, 2023 |
| 3Q22 | $231.223 | +$11.518 | 5 MG | Tacrolimus injection | v1, posted June 9, 2023 |
| 2Q22 | $219.705 | +$0.035 | 5 MG | Tacrolimus injection | v1, posted December 14, 2022 |
| 1Q22 | $219.67 | +$0.345 | 5 MG | Tacrolimus injection | v1, posted June 8, 2022 |
| 4Q21 | $219.325 | +$3.581 | 5 MG | Tacrolimus injection | v1, posted June 2, 2022 |
| 3Q21 | $215.744 | +$3.468 | 5 MG | Tacrolimus injection | v1, posted June 2, 2022 |
| 2Q21 | $212.276 | +$0.057 | 5 MG | Tacrolimus injection | v1, posted March 1, 2022 |
| 1Q21 | $212.219 | – | 5 MG | Tacrolimus injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.